rs1801483, GCGR

N. diseases: 7
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE In a combined French-Sardinian study of GCR , there is an association of Gly 40 Ser mutation with T2DM, confirmed by a UK study but not by others. 15931615 2005
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Our results show that the Gly40Ser mutation in the glucagon receptor gene is not associated with type 2 diabetes in a Brazilian population. 11961492 2002
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Our results demonstrate a strong genetic heterogeneity among the ethnic group and suggest that the Gly40Ser mutation of the glucagon receptor gene plays little role, if any, in the pathogenesis of type 2 diabetes and essential hypertension in the Taiwanese population. 10090412 1999
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Although the frequency of the Gly40Ser polymorphism in NIDDM observed in France is not confirmed in our population, this genetic variance is also evident in Germany. 10510728 1999
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE In conclusion, our results indicate that the Gly40Ser variation is not associated with NIDDM in the Sardinian population and that its frequency varies in different parts of Sardinia. 9028723 1997
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Our results suggest that Gly40Ser polymorphism of the GCG-R gene is not associated with NIDDM in the Russian population and point to the genetic heterogeneity of NIDDM in different ethnic groups. 9285210 1997
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Restricted geographical extension of the association of a glucagon receptor gene mutation (Gly40Ser) with non-insulin-dependent diabetes mellitus. 8858207 1996
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE We have previously reported that a single heterozygous missense mutation in exon 2 of the glucagon receptor gene, which changes a glycine to a serine (Gly40Ser), is associated with NIDDM in a French population. 8635644 1996
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Thus, the Gly40-Ser mutation does not play an important role in the pathogenesis of NIDDM in Japanese patients. 8879960 1996
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Absence of association between the Gly40-->Ser mutation in the human glucagon receptor and Japanese patients with non-insulin-dependent diabetes mellitus or impaired glucose tolerance. 8931690 1996
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Recently, subtypes of typical NIDDM were suggested based on missense mutations of mitochondrial DNA [tRNALeu(UUR)] and the glucagon receptor gene (Gly40Ser). 8732719 1996
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE None of the Japanese diabetic patients showed Gly40Ser mutation and the association of this mutation with NIDDM was significantly different (p < 4.10(-5) vs French, p < 3.10(-6) vs Sardinian by Fisher's exact test). 7589886 1995
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Taken together, the data do not support the suggested involvement of the Gly40Ser polymorphism in impaired glucose tolerance and the hypothesis of an association between NIDDM and the glucagon receptor gene in this population. 8690179 1995
Hypertensive disease
CUI: C0020538
Disease: Hypertensive disease
0.030 GeneticVariation BEFREE We conclude that the Gly40Ser polymorphism of the GCGR gene is associated with higher risk of hypertension and with enhanced proximal tubular sodium reabsorption, a factor possibly contributing to hypertension in this group. 11692154 2001
Hypertensive disease
CUI: C0020538
Disease: Hypertensive disease
0.030 GeneticVariation BEFREE The Gly40Ser polymorphism was not significantly associated with hypertension in the whole study population, although the frequency of 40Ser carriers in hypertensive subjects was double that in normotensive subjects (3.1% in hypertensives versus 1.5%; P=0.087). 10406817 1999
Essential Hypertension
CUI: C0085580
Disease: Essential Hypertension
0.030 GeneticVariation BEFREE Our results demonstrate a strong genetic heterogeneity among the ethnic group and suggest that the Gly40Ser mutation of the glucagon receptor gene plays little role, if any, in the pathogenesis of type 2 diabetes and essential hypertension in the Taiwanese population. 10090412 1999
Essential Hypertension
CUI: C0085580
Disease: Essential Hypertension
0.030 GeneticVariation BEFREE Glucagon receptor gene mutation (Gly40Ser) in human essential hypertension: the PEGASE study. 10406817 1999
Essential Hypertension
CUI: C0085580
Disease: Essential Hypertension
0.030 GeneticVariation BEFREE 1.Previous glucagon receptor gene (GCGR) studies have shown a Gly40Ser mutation to be more prevalent in essential hypertension and to affect glucagon binding affinity to its receptor. 9673441 1998
Hypertensive disease
CUI: C0020538
Disease: Hypertensive disease
0.030 GeneticVariation BEFREE No association of the Gly40Ser variant with hypertension was seen in this large population. 9325468 1997
Impaired glucose tolerance
CUI: C0271650
Disease: Impaired glucose tolerance
0.030 GeneticVariation BEFREE A total of 348 unrelated Japanese subjects (220 with NIDDM, 53 with impaired glucose tolerance (IGT) and 75 normal subjects) were screened for the presence of the Gly40-Ser mutation. 8879960 1996
Impaired glucose tolerance
CUI: C0271650
Disease: Impaired glucose tolerance
0.030 GeneticVariation BEFREE Absence of association between the Gly40-->Ser mutation in the human glucagon receptor and Japanese patients with non-insulin-dependent diabetes mellitus or impaired glucose tolerance. 8931690 1996
Impaired glucose tolerance
CUI: C0271650
Disease: Impaired glucose tolerance
0.030 GeneticVariation BEFREE Taken together, the data do not support the suggested involvement of the Gly40Ser polymorphism in impaired glucose tolerance and the hypothesis of an association between NIDDM and the glucagon receptor gene in this population. 8690179 1995
Diabetes Mellitus
CUI: C0011849
Disease: Diabetes Mellitus
0.020 GeneticVariation BEFREE Patients with diabetes and carriers of Gly40Ser showed basal C-peptide levels significantly lower than noncarriers (0.70 ng/mL versus 1.50 ng/mL, p = 0.008). 11961492 2002
Diabetes Mellitus
CUI: C0011849
Disease: Diabetes Mellitus
0.020 GeneticVariation BEFREE A mutation in the glucagon receptor gene (Gly40Ser): heterogeneity in the association with diabetes mellitus. 7589886 1995
Diabetes
CUI: C0011847
Disease: Diabetes
0.010 GeneticVariation BEFREE Patients with diabetes and carriers of Gly40Ser showed basal C-peptide levels significantly lower than noncarriers (0.70 ng/mL versus 1.50 ng/mL, p = 0.008). 11961492 2002